Results 191 to 200 of about 49,838,108 (340)

Value-at-Risk Bounds with Variance Constraints

, 2015
Carole Bernard, L. Rüschendorf, S. Vanduffel   +2 more
semanticscholar   +1 more source

Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer

Molecular Oncology, EarlyView.
Cancer cells' high translational demand creates opportunities to therapeutically target ribosome function. Ribosome stalling and collisions activate ZAKα and the ribotoxic stress response (RSR), which can trigger rapid, p53‐independent apoptosis in cancer.
Anastassiya Kim, Maryam Aslam, Elouise Torruella, Alphons Sony, Asif Rahman, Simira Smith, Columba de la Parra, Moira Sauane   +7 more
wiley   +1 more source

Pan-immune-inflammation value for risk stratification of adverse cardiovascular outcomes in acute coronary syndrome undergoing percutaneous coronary intervention: a systematic review and meta-analysis. [PDF]

Front Immunol
Yin X, Du S.
europepmc   +1 more source

Value-at-Risk Based Risk Management: Optimal Policies and Asset Prices

, 1999
Suleyman Basak, A. Shapiro
semanticscholar   +1 more source

Value at Risk (VaR) and the alpha-stable distribution [PDF]

Volatility in financial markets is a matter of considerable concern to financial institutions and their supervisors. Already it is clear that this volatility has had an adverse effect on the real economy.
John C. Frain
core  

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

Molecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic, Rafael Stroggilos, Mladen Marinkovic, Ana Djuric, Suzana Stojanovic‐Rundic, Radmila Jankovic, Sergi Castellvi‐Bel, Remond J.A. Fijneman, Antonia Vlahou, Jerome Zoidakis, Milena Cavic   +10 more
wiley   +1 more source

Skeletal Muscle Gauge and Complementary Pan-Immune-Inflammation Value for Risk Stratification of 30-Day Major Complications After Colorectal Cancer Surgery. [PDF]

Biomedicines
Kiss BI, Sala DT, Moriczi R, Gábor SA, Török Á, Muresan GM, Bara T, Dénes MI, Kiss SL, Kiss SL, Kiss-Toth O, Neagoe RM.   +11 more
europepmc   +1 more source

Beyond Value‐at‐Risk: GlueVaR Distortion Risk Measures

Risk Analysis, 2014
Jaume Belles-Sampera, Montserrat Guillén, Miguel Santolino   +2 more
semanticscholar   +1 more source

The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer

Molecular Oncology, EarlyView.
Mutations, environmental stress, and chaperone dysfunction can destabilize pVHL, promoting its conversion from the native folded state into amyloid‐like assemblies. This transition may contribute to protein storage, cell dormancy, survival, and drug resistance.
Lara Abad, Silvio Carlo Ermanno Tosatto, Emanuela Leonardi   +2 more
wiley   +1 more source

The predictive value of risk assessment models for venous thromboembolism on gynaecological cancer patients. [PDF]

J Coll Med S Afr
Ratshabedi PK, Chikandiwa A, Mbodi L.
europepmc   +1 more source